The potential of subanesthetic intravenous ketamine as an effective and non-inferior alternative to electroconvulsive therapy (ECT) for treating non-psychotic, treatment-resistant depression has been unveiled by a groundbreaking study led by researchers from Mass General Brigham. Published in the prestigious New England Journal of Medicine, the study’s findings offer hope for individuals grappling with severe depression… Read More »
Antipsychotic Drug Along With Antidepressant Benefit Older Adults With Depression
and are to be presented that same day by Eric J. Lenze, MD principal investigator and head of the Department of Psychiatry at Washington University and colleagues at the annual meeting of the American Association for Geriatric Psychiatry in New Orleans. Many people with clinical depression don’t respond to medications used to treat… Read More »
